Bloom Energy’s October Stock Slump Deepens: Options Signal Post-Earnings Bounce to $230
The options market is predicting that the Bloom Energy stock may rebound to $230 after the company publishes its earnings today.
Stocks · News reference
CEO.CA's 'Inside the Boardroom' Features Marvel Biosciences President Dr. Mark Williams
Marvel Biosciences Corp. President and Chief Science Officer Dr. Mark Williams discusses the company's lead drug candidate, MB-204, and its progress toward human clinical trials.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- fiscal.ai
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Marvell Feels Supply Chain Bottlenecks Pressure, Stock Drops Amid Tech Sell-Off
Marvell stock fell nearly 8% Thursday as weakness in the broader tech sector overshadowed strong demand for AI chips.
Buying This Stock Right Now Could Be a Once-in-a-Generation Opportunity
Marvell Technology is positioned as a major beneficiary of AI infrastructure growth, with management raising fiscal 2028 revenue guidance to $20 billion and targeting $70-90 billion by fiscal 2031. The company supplies custom AI chips and data center networking technology to major tech companies. Analysts project the stock could potentially triple to $750 by 2031 if the company meets its earnings targets, though competition from Broadcom and potential slowdowns in AI spending present risks.